Amgen invests $300M to expand U.S. biomanufacturing, boosting supply chain and jobs in Puerto Rico.

Amgen announced a $300 million investment to expand its biomanufacturing facility in Puerto Rico, enhancing U.S.-based production capacity and supporting a reliable medicine supply. This expansion will create hundreds of construction jobs and strengthen advanced manufacturing roles, reinforcing Amgen's commitment to American manufacturing and supply chain resilience. The investment builds on previous commitments totaling over $2.7 billion across multiple U.S. locations, reflecting confidence in domestic biomanufacturing and workforce development. This move supports long-term innovation and job growth in the U.S. biotech sector.